FGFR2 Inhibitor Nabs Speedy Approval for Cholangiocarcinoma
The FDA granted accelerated approval to futibatinib (Lytgobi) tablets for treating adults…
Browsing Tag
cholangiocarcinoma
Intrahepatic Cholangiocarcinoma Clinical Trial Pipeline Shows Rapid Progress with 20+…
New York, USA, April 06, 2022 (GLOBE NEWSWIRE) -- Intrahepatic Cholangiocarcinoma Clinical Trial Pipeline Shows Rapid Progress with 20+ Companies Working to Develop Therapies, Assesses…
Initiative to map the cholangiocarcinoma (CCA) landscape in Europe will help improve…
Bile duct cancer, also known as cholangiocarcinoma (CCA), is a rare cancer often diagnosed only at an advanced stage. A comprehensive analysis of diagnostic, prognostic, and therapeutic…